Pricing

Ideaya Biosciences Inc (IDYA)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Yujiro S. Hata
Employees: 80
Web site: ideayabio.com
7000 SHORELINE COURT, SUITE 350, SOUTH SAN FRANCISCO, CA, 94080
650-443-6209
All 13F Filers Prior Change Hedge Funds 1 Prior Change
IDEAYA Biosciences, Inc. focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available